⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2059700 | 1.00 | — | — | |
| SCHEMBL28529681 | 0.79 | — | — | |
| SCHEMBL12345822 | 0.79 | — | — | |
| SCHEMBL3804219 | 0.77 | — | — | |
| SCHEMBL4681859 | 0.75 | GRIK1 (0.46) | — | |
| SCHEMBL1323858 | 0.75 | GRIK1 (0.41) | — | |
| SCHEMBL7353894 | 0.75 | TP53 (0.36) | — | |
| SCHEMBL6573659 | 0.73 | — | — | |
| SCHEMBL27983572 | 0.73 | GRIK1 (0.40) | — | |
| SCHEMBL21716 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12558432-B2 | Biocompatible polymeric drug carriers for delivering active agents | CIS BIOPHARMA AG (CH) | 2026-02-24 | — | — | US | claimed |
| US-20220409737-A1 | BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS | CIS BIOPHARMA AG (CH) | 2022-12-29 | — | — | US | claimed |
| EP-4051320-A1 | BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS | CIS Pharma AG (CH) | 2022-09-07 | — | — | EP | claimed |
| CN-114641316-A | Biocompatible polymeric drug carriers for delivery of active agents | CIS制药股份公司 | 2022-06-17 | — | — | CN | claimed |
| WO-2021084087-A1 | BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS | CIS PHARMA AG (CH) | 2021-05-06 | — | — | WO | claimed |
| EP-0521453-B1 | Polymeric vehicle for coatings | UNIV NORTH DAKOTA (US) | 1996-06-05 | — | — | EP | claimed |
| US-20260055182-A1 | ANTI-L1-CAM ANTIBODIES AND THEIR USES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | CIS BIOPHARMA AG (CH) | 2026-02-26 | — | — | US | disclosed |
| US-12558432-B2 | Biocompatible polymeric drug carriers for delivering active agents | CIS BIOPHARMA AG (CH) | 2026-02-24 | — | — | US | disclosed |
| EP-4615580-A1 | ANTI-L1-CAM ANTIBODIES AND THEIR USES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | CIS Biopharma AG (CH) | 2025-09-17 | — | — | EP | disclosed |
| WO-2024100200-A1 | ANTI-L1-CAM ANTIBODIES AND THEIR USES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | CIS PHARMA AG (CH) | 2024-05-16 | — | — | WO | disclosed |
| CN-117396575-A | Main agent for adhesive, adhesive composition, and adhesive film | 三洋化成工业株式会社 | 2024-01-12 | — | — | CN | disclosed |
| US-20220409737-A1 | BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS | CIS BIOPHARMA AG (CH) | 2022-12-29 | — | — | US | disclosed |
| EP-4051320-A1 | BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS | CIS Pharma AG (CH) | 2022-09-07 | — | — | EP | disclosed |
| EP-0860213-A2 | Bioactive coating on surfaces | HÜLS AKTIENGESELLSCHAFT (DE) | 1998-08-26 | — | — | EP | disclosed |
| EP-0852952-A2 | Bioactive coating of surfaces | HÜLS AKTIENGESELLSCHAFT (DE) | 1998-07-15 | — | — | EP | disclosed |
| EP-0852238-A2 | Polymers with bacteriophobe and optionally cell proliferation inhibitant properties | HÜLS AKTIENGESELLSCHAFT (DE) | 1998-07-08 | — | — | EP | disclosed |
| EP-0794199-A2 | Novel functional polymers | WAKO PURE CHEMICAL INDUSTRIES, LTD (JP) | 1997-09-10 | — | — | EP | disclosed |
| EP-0027719-B1 | THERMOSETTING COATING COMPOSITION | FORD MOTOR COMPANY LIMITED (GB) | 1983-07-13 | — | — | EP | disclosed |
| US-4297448-A | AUTOMOBILES | FORD MOTOR COMPANY (US) | 1981-10-27 | — | — | US | disclosed |
| EP-0008345-A1 | Hexahydropyrimidyl-4 ethers and process for their preparation | BASF Aktiengesellschaft (DE) | 1980-03-05 | — | — | EP | disclosed |